Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer

BACKGROUND: The prognostic value of lymphovascular invasion (LVI) in breast cancer (BC) has been demonstrated in several independent studies. However, identification of driver molecules for LVI remains a challenging task. Large-scale transcriptomic profiling of histologically validated LVI can poten...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Aleskandarany, Mohammed A, Sonbul, Sultan, Surridge, Rachel, Mukherjee, Abhik, Caldas, Carlos, Diez-Rodriguez, Maria, Ashankyty, Ibraheem, Albrahim, Khalil I, Elmouna, Ahmed M, Aneja, Ritu, Martin, Stewart G, Ellis, Ian O, Green, Andrew R, Rakha, Emad A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Molecular Diagnostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674094/
https://ncbi.nlm.nih.gov/pubmed/28829761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.261
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars